Hetrombopag clinical trials
Also written SHR8735.
Includes 24 studies of Hetrombopag olamine.
How each study uses hetrombopag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the hetrombopag studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
53 studies that test it; most in 2022 (10)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 23 · Other 30
Jiangsu HengRui Medicine Co., Ltd. (22) · Institute of Hematology & Blood Diseases Hospital, China (4) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (4) · Peking Union Medical College Hospital (3) · Henan Cancer Hospital (2) · Sun Yat-sen University (2) · Fujian Cancer Hospital (2) · Atridia Pty Ltd. (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 9, 1 in phase 3
Studies that test hetrombopag, phase 3 first.
- Sep 2027Hetrombopag for Thrombocytopenia in Patients Scheduled for Elective Hepatic Interventional Diagnostic and Therapeutic Procedures: A Clinical StudyPhase 3 · Zhongda Hospital
- Dec 2026A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPPhase 2 · Institute of Hematology & Blood Diseases Hospital, China
- Apr 2027A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor TherapyPhase 2 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Apr 2027A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyPhase 2 · Shanghai Pulmonary Hospital, Shanghai, China
- Apr 2027Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With NeuroblastomaNot applicable · Beijing Children's Hospital
- Jun 2027TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationPhase 2 · Peking Union Medical College Hospital
- Oct 2027Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With HerombopagNot applicable · Zhenzhen Liu
- Nov 2027A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.Phase 2 · Sun Yat-sen University
- Nov 2027Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyPhase 2 · Fujian Cancer Hospital
Studies
Open first, then newest update. How each study uses hetrombopag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 53
- Hetrombopag for Thrombocytopenia in Patients Scheduled for Elective Hepatic Interventional Diagnostic and Therapeutic Procedures: A Clinical StudyNot yet recruitingPhase 3Zhongda HospitalNCT07925398Written as HetrombopagHow we know
- A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)RecruitingPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT07286032Written as Hetrombopag OlamineHow we know
- Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal TumorsRecruitingPhase 2Changhai HospitalNCT07492693Written as HetrombopagHow we know
- A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor TherapyNot yet recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07408648Written as hetrombopag 7.5 mg orally once dailyHow we know
- A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.Not yet recruitingPhase 2Sun Yat-sen UniversityNCT07334093Written as rhTPO + hetrombopagHow we know
- Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With NeuroblastomaRecruitingNot applicableBeijing Children's HospitalNCT06818916Written as HetrombopagHow we know
- Herombopag Treated T-DM1 Induced Platelet ReductionRecruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07257809Written as Herombopag Olamine TabletsHow we know
- A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal CarcinomaNot yet recruitingPhase 2Fujian Cancer HospitalNCT07252375Written as herombopag olamine tabletsHow we know
- Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 StudyNot yet recruitingPhase 2Fujian Cancer HospitalNCT07243418Written as herombopag olamine tabletsHow we know
- Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With HerombopagNot yet recruitingNot applicableZhenzhen LiuNCT07198672Written as HerombopagHow we know
- A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer TherapyNot yet recruitingPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT07101627Written as Hetrombopag TabletsHow we know
- A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITPRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06838949Written as herombopag olamine tabletsHow we know
- Herombopag for Chemotherapy-induced ThrombocytopeniaRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT05236582Written as HerombopagHow we know
- Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical CancerNot yet recruitingPhase 2Peking University Cancer Hospital & InstituteNCT06745219Written as herombopagHow we know
- Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of ThrombocytopeniaRecruitingPhase 4The Third People's Hospital of ChengduNCT06562738Written as HetrombopagHow we know
- TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingPhase 2Peking Union Medical College HospitalNCT06478537Written as Hetrombopag OlamineHow we know
- Hetrombopag for the Thrombocytopenia Induced by Concurrent ChemoradiotherapyRecruitingPhase 2Sir Run Run Shaw HospitalNCT06433830Written as Hetrombopag OlamineHow we know
- Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.Not yet recruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT06346925Written as Herombopag Olamine TabletsHow we know
- Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before HepatectomyRecruitingPhase 2Fudan UniversityNCT05442632Written as HetrombopagHow we know
- The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic MalignanciesNot yet recruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT06099925Written as HetrombopagHow we know
See all 53 studies that test hetrombopag →
Given beside what is tested · 1 — hetrombopag is usual care or a partner of the new treatment
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
Codes
What other systems call hetrombopag · ClinicalTrials.gg INT000612
- MeSH (NLM) C000614661hetrombopagConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 9WGT51BDDLRAFUTROMBOPAGConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000614661 | hetrombopag | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 9WGT51BDDL | RAFUTROMBOPAG | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.